Search Results - Daniel Vis

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Emergence of De Novo Conditions Following Remission of Cushing Syndrome: A Case Report and Scoping Review by Noémie Desgagnés, Laura Senior, Daniel Vis, Katayoun Alikhani, Kirstie Lithgow

    Published in Endocrinology, Diabetes & Metabolism (2024-05-01)
    Get full text
    Article


  2. 2

    TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth by Sander AL Palit, Daniel Vis, Suzan Stelloo, Cor Lieftink, Stefan Prekovic, Elise Bekers, Ingrid Hofland, Tonći Šuštić, Liesanne Wolters, Roderick Beijersbergen, Andries M Bergman, Balázs Győrffy, Lodewyk FA Wessels, Wilbert Zwart, Michiel S van der Heijden

    Published in eLife (2019-12-01)
    Get full text
    Article


  3. 3

    Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer by Khrystany T. Isebia, Anouk C. deJong, Lisanne F. vanDessel, Vanja deWeerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job vanRiet, Paul Hamberg, Daniel Vis, Michiel S. van derHeijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald deWit, Maurice P. H. M. Jansen, John W. M. Martens

    Published in Molecular Oncology (2025-10-01)
    Get full text
    Article


  4. 4

    Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer by Xiaolin Zhu, Tatyanah Farsh, Daniël Vis, Ivan Yu, Haolong Li, Tianyi Liu, Martin Sjöström, Raunak Shrestha, Jeroen Kneppers, Tesa Severson, Meng Zhang, Arian Lundberg, Thaidy Moreno Rodriguez, Alana S. Weinstein, Adam Foye, Niven Mehra, Rahul R. Aggarwal, Andries M. Bergman, Eric J. Small, Nathan A. Lack, Wilbert Zwart, David A. Quigley, Michiel S. van der Heijden, Felix Y. Feng

    Published in The Journal of Clinical Investigation (2024-10-01)
    Get full text
    Article


Search Tools: